Cargando…
Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin
Podoplanin (PDPN), a type I transmembrane sialoglycoprotein, is expressed in normal tissues, including lymphatic endothelial cells, pulmonary type I alveolar cells, and renal podocytes. The overexpression of PDPN in cancers is associated with hematogenous metastasis by interactions with the C-type l...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208159/ https://www.ncbi.nlm.nih.gov/pubmed/30362926 http://dx.doi.org/10.1089/mab.2018.0035 |
_version_ | 1783366658689073152 |
---|---|
author | Kato, Yukinari Mizuno, Takuya Yamada, Shinji Nakamura, Takuro Itai, Shunsuke Yanaka, Miyuki Sano, Masato Kaneko, Mika K. |
author_facet | Kato, Yukinari Mizuno, Takuya Yamada, Shinji Nakamura, Takuro Itai, Shunsuke Yanaka, Miyuki Sano, Masato Kaneko, Mika K. |
author_sort | Kato, Yukinari |
collection | PubMed |
description | Podoplanin (PDPN), a type I transmembrane sialoglycoprotein, is expressed in normal tissues, including lymphatic endothelial cells, pulmonary type I alveolar cells, and renal podocytes. The overexpression of PDPN in cancers is associated with hematogenous metastasis by interactions with the C-type lectin-like receptor 2 (CLEC-2). We have previously reported the development of a mouse monoclonal antibody (mAb) clone, PMab-38 (IgG(1), kappa), against dog PDPN (dPDPN). PMab-38 reacted strongly with canine squamous cell carcinomas and melanomas, but not with lymphatic endothelial cells, indicating its cancer specificity. In this study, we developed and produced several mouse-canine chimeric antibodies originating from PMab-38. A mouse-canine chimeric antibody of subclass A (P38A) and a mouse-canine chimeric antibody of subclass B (P38B) were transiently produced using ExpiCHO-S cells. Core-fucose-deficient P38B (P38Bf) was developed using FUT8 knockout ExpiCHO-S cells. We compared the binding affinities, antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC) of P38A, P38B, and P38Bf against Chinese hamster ovary (CHO)/dPDPN cells. Flow cytometry analysis showed that the K(D) of P38A, P38B, and P38Bf were 1.9 × 10(−7), 5.2 × 10(−9), and 6.5 × 10(−9), respectively. Both P38B and P38Bf revealed high ADCC activities against CHO/dPDPN cells; P38Bf demonstrated significantly higher ADCC compared with P38B, especially at low concentrations. P38B and P38Bf exhibited higher CDC activities against CHO/dPDPN cells. Conversely, P38A did not exhibit any ADCC or CDC activity. In summary, P38Bf is a good candidate for antibody therapy against dPDPN-expressing canine cancers. |
format | Online Article Text |
id | pubmed-6208159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-62081592018-10-31 Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin Kato, Yukinari Mizuno, Takuya Yamada, Shinji Nakamura, Takuro Itai, Shunsuke Yanaka, Miyuki Sano, Masato Kaneko, Mika K. Monoclon Antib Immunodiagn Immunother Original Articles Podoplanin (PDPN), a type I transmembrane sialoglycoprotein, is expressed in normal tissues, including lymphatic endothelial cells, pulmonary type I alveolar cells, and renal podocytes. The overexpression of PDPN in cancers is associated with hematogenous metastasis by interactions with the C-type lectin-like receptor 2 (CLEC-2). We have previously reported the development of a mouse monoclonal antibody (mAb) clone, PMab-38 (IgG(1), kappa), against dog PDPN (dPDPN). PMab-38 reacted strongly with canine squamous cell carcinomas and melanomas, but not with lymphatic endothelial cells, indicating its cancer specificity. In this study, we developed and produced several mouse-canine chimeric antibodies originating from PMab-38. A mouse-canine chimeric antibody of subclass A (P38A) and a mouse-canine chimeric antibody of subclass B (P38B) were transiently produced using ExpiCHO-S cells. Core-fucose-deficient P38B (P38Bf) was developed using FUT8 knockout ExpiCHO-S cells. We compared the binding affinities, antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC) of P38A, P38B, and P38Bf against Chinese hamster ovary (CHO)/dPDPN cells. Flow cytometry analysis showed that the K(D) of P38A, P38B, and P38Bf were 1.9 × 10(−7), 5.2 × 10(−9), and 6.5 × 10(−9), respectively. Both P38B and P38Bf revealed high ADCC activities against CHO/dPDPN cells; P38Bf demonstrated significantly higher ADCC compared with P38B, especially at low concentrations. P38B and P38Bf exhibited higher CDC activities against CHO/dPDPN cells. Conversely, P38A did not exhibit any ADCC or CDC activity. In summary, P38Bf is a good candidate for antibody therapy against dPDPN-expressing canine cancers. Mary Ann Liebert, Inc., publishers 2018-10-01 2018-10-24 /pmc/articles/PMC6208159/ /pubmed/30362926 http://dx.doi.org/10.1089/mab.2018.0035 Text en © Yukinari Kato et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Kato, Yukinari Mizuno, Takuya Yamada, Shinji Nakamura, Takuro Itai, Shunsuke Yanaka, Miyuki Sano, Masato Kaneko, Mika K. Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
title | Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
title_full | Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
title_fullStr | Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
title_full_unstemmed | Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
title_short | Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
title_sort | establishment of p38bf, a core-fucose-deficient mouse-canine chimeric antibody against dog podoplanin |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208159/ https://www.ncbi.nlm.nih.gov/pubmed/30362926 http://dx.doi.org/10.1089/mab.2018.0035 |
work_keys_str_mv | AT katoyukinari establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT mizunotakuya establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT yamadashinji establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT nakamuratakuro establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT itaishunsuke establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT yanakamiyuki establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT sanomasato establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin AT kanekomikak establishmentofp38bfacorefucosedeficientmousecaninechimericantibodyagainstdogpodoplanin |